Performance of large-volume versus small-volume holding chambers with chlorofluorocarbon-albuterol and hydrofluoroalkane-albuterol sulfate

Respiratory Care

Volumn 44, Issue 1, 1999, Pages 38-44

  Mitchell, Jolyon P ^a,c   Nagel, Mark W ^a   Rau, Joseph L ^b  

^a TRUDELL MEDICAL INTERNATIONAL   (Canada)

^b GEORGIA STATE UNIVERSITY   (United States)

^c Medical Aerosol Laboratory   (Canada)

Author keywords

Aerosol propellants; Albuterol; Bronchodilator aerosols; Chlorofluorocarbon; Drug delivery; Holding chambers; Hydrofluoroalkane; In vitro studies; Metered dose inhalers

Indexed keywords

BRONCHODILATING AGENT; CHLOROFLUOROCARBON; FLUORINATED HYDROCARBON; PROPELLANT; SALBUTAMOL; SALBUTAMOL SULFATE;

AEROSOL; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; DOG; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; NONHUMAN; PARTICLE SIZE;

EID: 6544232840     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Riker Laboratories Inc. Self-propelling, powder-dispensing compositions. US Paient 837465, 1960.
2. Barry PW, O'Callaghan C The optimum size and shape of spacer devices for inhalational therapy J Aerosol Med 1995;8(3):303-305.
3. Morén F. Drug deposition of pressurized inhalation aerosots. I. Influence of actuator tube design. Int J Pharm 1978;1:205-212.
4. Corr D, Dolovich M, McCormack R, Ruffin R, Obminski G, Newhouse M. Design and characteristics of a portable breath actuated, particle size selective medical aerosol inhaler. J Aerosol Sci 1982; 13(1):1-7
5. Rau JL, Mitchell JP, Nagel MW, Coppolo D Assessment of large and small volume holding chamber performance with HFA-formulated albuterol (abstract). Chest 1996;110(4 Suppl):82S.
6. Barry PW, O'Callaghan C. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices. Eur Respir J 1997;10(6):1345-1348.
7. Lippmann M, Yeates DB, Albert RE. Deposition, retention, and clearance of inhaled particles (review). Br J Ind Med 1980;37(4): 337-362.
8. Wildhaber JH, Devadason SG, Hayden MJ, James R, Dufry AP, Fox RA. et al. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J 1996;9(9):1943-1946.
9. Dolovich MB. Lung dose, distribution, and clinical response to therapeutic aerosols. Aerosol Sci Technol 1993;18:230-240.
10. Wildhaber JH, Hayden MJ, Dore ND, Devadason SG. LeSouėf PN, Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study. Chest 1998;113(1):186-191.
11. Schulz D, Carlson S, Ross D. In vitro performance characteristics of two CFC-free metered dose inhalers (MDIs) with large and small volume spacers. Eur Resp J 1996;9(S23):255.
12. Donnell D, Harrison LI, Ward S, Klinger NM, Ekholm BP, Coper KM, et al. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler. Eur J Clin Pharmacol 1995; 48(6):473-477.
13. Nogami-Itoh M, Yakuo I, Hammerbeck DM, Miller RL, Takeyama K. The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs. Pharm Res 1997;14(2):208-212.
14. Dockhorn RJ, Wagner DE, Burgess GL, Hafner KB, Letourneau K, Colice GL, Klinger NM. Proventil® HFA provides protection from exercise-induced bronchoconstricuon comparable to Proventil® and Ventolin®. Ann Allergy Asthma Immunol 1997;79(1):85-88.
15. Kleerup EC, Tashkin DP, Cline AC, Ekholm BP. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma. Chest 1996;109(3): 702-707.